Search - tctmd.com

Displaying 741 - 760 of 7326

Sort: Relevancy | Date

Presentation TCT 2024

The Trisol TTVR System: Technology Differentiation and Early Clinical Experience

Presenter: Isaac George

October 29, 2024

Presentation TCT 2024

Current and Future Clinical Evidence of SELUTION SLR™ DEB

Presenter: Simon Eccleshall

October 29, 2024

Presentation TCT 2024

Case 3: TR with Large Gaps and a Large Annulus

Presenter: Rishi Puri

October 29, 2024

Presentation TCT 2024

The LuX-Valve Plus Transjugular TTVR System: One-Year Outcomes of a Multicenter Clinical Study in High Surgical Risk TR Patients

Presenter: Juan Granada

October 29, 2024

Presentation TCT 2024

The Intrepid TTVR Clinical Program

Presenter: Firas Zahr

October 29, 2024

Presentation TCT 2024

What Next After Establishing the Diagnosis: Risk Stratification for Acute PE

Presenter: Amir Darki

October 29, 2024

Presentation TCT 2024

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Presenter: Samir Kapadia

October 29, 2024

Presentation TCT 2024

Health Equity in the Care of the Pulmonary Embolism Patient

Presenter: Peter Monteleone

October 29, 2024

Presentation TCT 2024

The Cardiovalve TTVR Clinical Program

Presenter: Christian Frerker

October 29, 2024

Presentation TCT 2024

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

Presenter: Didier Tchetche

October 29, 2024

Presentation TCT 2024

PE in 2024: Why Should Cardiologist Care?

Presenter: Sripal Bangalore

October 29, 2024

Presentation TCT 2024

Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial

Presenter: Tobias Rheude

October 29, 2024

Presentation TCT 2024

Case 2: Device Choice for TR When RV Leads Are Present

Presenter: Christian Besler

October 29, 2024

Presentation TCT 2024

Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial

Presenter: Thomas Pilgrim

October 29, 2024

Presentation TCT 2024

Case 1: Atrial Functional TR - Preferred Device Choices

Presenter: Mirjam Wild

October 29, 2024

Presentation TCT 2024

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

Presenter: Torsten Vahl

October 29, 2024

Presentation TCT 2024

It's Not Just About Mortality! - Quality of Life Factors in Pulmonary Embolism Care

Presenter: Teresa Carman

October 29, 2024

Presentation TCT 2024

What is in the Toolbox for Chronic PE?

Presenter: Vikas Aggarwal

October 29, 2024

Presentation TCT 2024

Role of Mechanical Circulatory Support in Acute PE Intervention

Presenter: Joshua Goldberg

October 29, 2024

Presentation TCT 2024

Not Every PE Needs a Procedure! Key Elements to Consider in the Non-Procedural Patient

Presenter: Behnood Bikdeli

October 29, 2024

Advertisement

The Trisol TTVR System: Technology Differentiation and Early Clinical Experience

Current and Future Clinical Evidence of SELUTION SLR™ DEB

Case 3: TR with Large Gaps and a Large Annulus

The LuX-Valve Plus Transjugular TTVR System: One-Year Outcomes of a Multicenter Clinical Study in High Surgical Risk TR Patients

The Intrepid TTVR Clinical Program

What Next After Establishing the Diagnosis: Risk Stratification for Acute PE

Cerebral Embolic Protection in the US Cohort of the PROTECTED TAVR Trial

Health Equity in the Care of the Pulmonary Embolism Patient

The Cardiovalve TTVR Clinical Program

Transcatheter vs. Surgical Aortic Valve Replacement in Women: A Pooled Analysis of the RHEIA and PARTNER 3 Trials

PE in 2024: Why Should Cardiologist Care?

Comparison of Strategies for Vascular Access Closure After Transcatheter Aortic Valve Implantation: The ACCESS-TAVI Randomized Trial

Case 2: Device Choice for TR When RV Leads Are Present

Colchicine in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Double-Blind Randomized Controlled Trial

Case 1: Atrial Functional TR - Preferred Device Choices

The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation

It's Not Just About Mortality! - Quality of Life Factors in Pulmonary Embolism Care

What is in the Toolbox for Chronic PE?

Role of Mechanical Circulatory Support in Acute PE Intervention

Not Every PE Needs a Procedure! Key Elements to Consider in the Non-Procedural Patient

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content